{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:36:43Z","timestamp":1781195803774,"version":"3.54.1"},"reference-count":45,"publisher":"Informa UK Limited","issue":"19","funder":[{"name":"Clinical Research Special Fund of Wu Jieping Medical Foundation","award":["320.6750.2021-02-51"],"award-info":[{"award-number":["320.6750.2021-02-51"]}]},{"name":"Clinical Research Special Fund of Wu Jieping Medical Foundation","award":["320.6750.2021-17-13"],"award-info":[{"award-number":["320.6750.2021-17-13"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172865"],"award-info":[{"award-number":["82172865"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Start-up fund of Shandong Cancer Hospital","award":["2020-B14"],"award-info":[{"award-number":["2020-B14"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.2217\/fon-2023-0076","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T13:28:40Z","timestamp":1682688520000},"page":"1367-1378","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Nab-Paclitaxel Plus PD-1\/PD-L1 Inhibitor on Chemorefractory Relapsed Small-Cell Lung Cancer"],"prefix":"10.1080","volume":"19","author":[{"given":"Fengchun","family":"Mu","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital &amp; Institute,Shandong First Medical University &amp; Shandong Academy of Medical Sciences,\rJinan, 250117,\rShandong,\rChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital &amp; Institute,Shandong First Medical University &amp; Shandong Academy of Medical Sciences,\rJinan, 250117,\rShandong,\rChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital &amp; Institute,Shandong First Medical University &amp; Shandong Academy of Medical Sciences,\rJinan, 250117,\rShandong,\rChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenru","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital &amp; Institute,Shandong First Medical University &amp; Shandong Academy of Medical Sciences,\rJinan, 250117,\rShandong,\rChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunni","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital &amp; Institute,Shandong First Medical University &amp; Shandong Academy of Medical Sciences,\rJinan, 250117,\rShandong,\rChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital &amp; Institute,Shandong First Medical University &amp; Shandong Academy of Medical Sciences,\rJinan, 250117,\rShandong,\rChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2231-6642","authenticated-orcid":false,"given":"Linlin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital &amp; Institute,Shandong First Medical University &amp; Shandong Academy of Medical Sciences,\rJinan, 250117,\rShandong,\rChina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"World Health Organization (WHO) . Estimated number of prevalent cases (5-year) in 2020 lung both sexes all ages.https:\/\/gco.iarc.fr\/today\/online-analysis-pie?v=2020&mode=population&mode_population=countries&population=900&populations=900&key=total&sex=0&cancer=15&type=2&statistic=5&prevalence=1&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.10.002"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00235-0"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.03.207"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.8595"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx222"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30104-8"},{"key":"e_1_3_5_11_1","unstructured":"Ganti AKP LooBWJr BassettiMet al. NCCN Clinical Practice Guidelines in Oncology: small-cell lung cancer version 3.2023. http:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1462"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.5821"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0690-1"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.5392"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30068-1"},{"issue":"8","key":"e_1_3_5_16_1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/0959-8049(94)90455-3","article-title":"Activity of docetaxel (taxotere) in small cell lung cancer","volume":"30","author":"JF Smyth IES","year":"1994","unstructured":"JF Smyth IES , SessaC, SchoffskiP, WandersJ, FranklinH, KayeSB. Activity of docetaxel (taxotere) in small cell lung cancer. Eur. J. Cancer30A(8), 1058\u20131060 (1994).","journal-title":"Eur. J. Cancer"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2015.061"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl375"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.10.013"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.10.21"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24753"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008322932251"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2016.887"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0845-3"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007884"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01838-2016"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32222-6"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809064"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30098-5"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.01.008"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.10.003"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-042020-042741"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1634"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1593\/tlo.09109"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S88023"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31953-X"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0316-z"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30539-8"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.16464"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01055"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.967559"},{"key":"e_1_3_5_42_1","volume-title":"International Association for the Study of Lung Cancer 2022 World Conference on Lung Cancer.","author":"Owen DW","year":"2022","unstructured":"Owen DW , WeiL, BrennerBet al. Efficacy of nivolumab and temozolomide in extensive stage small cell lung cancer after chemo-immunotherapy. Presented at: International Association for the Study of Lung Cancer 2022 World Conference on Lung Cancer.Vienna, Austria, Abstract OA12.04 (2022)."},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00793"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.9000"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-03017-z"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80011"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.07.020"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2023-0076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:47:01Z","timestamp":1719125221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2023-0076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":45,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.2217\/fon-2023-0076"],"URL":"https:\/\/doi.org\/10.2217\/fon-2023-0076","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}